Effect of Dementia Caregiver Interventions on Healthcare Cost
痴呆症护理人员干预对医疗费用的影响
基本信息
- 批准号:8609634
- 负责人:
- 金额:$ 21.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-30 至 2016-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptionAfrican AmericanAgingAlzheimer&aposs DiseaseBehaviorBehavior TherapyCaregiver BurdenCaregiversCaringCaucasiansCaucasoid RaceCharacteristicsClinicalClinical DataConfounding Factors (Epidemiology)Cost SavingsDataDementiaEconomicsElderlyEthnic OriginEthnic groupExpenditureFundingGoalsHealthHealth Care CostsHealthcareHealthcare SystemsHispanicsHome environmentIncentivesInterventionKnowledgeLatinoMeasuresMedicareMedicare claimMental DepressionNational Institute of Nursing ResearchNational Institute on AgingOutcomeParticipantPatient CarePatientsPhysiciansQuality of lifeRaceRandomized Controlled TrialsReportingResourcesSiteSocioeconomic StatusTimeTranslationsVeteransVisitarmbasecaregivingclinical practicecomparison groupcopingcosthealth care service utilizationimprovedpublic health relevanceracial and ethnicsuccessful interventiontherapy designtreatment as usual
项目摘要
Although behavioral interventions for dementia caregivers have been shown to decrease caregiver
stress and burden, there has been little examination of their effects on healthcare costs for patients or
caregivers. This lack of information on interventions' impact on healthcare costs, particularly for dementia
patients, has likely impeded widespread adoption of successful interventions. The proposed study addresses
important knowledge gaps in our understanding of whether a successful behavioral intervention for caregivers
has an impact on actual healthcare costs for patients and caregivers and whether those impacts vary based on
caregiver and patient characteristics. Our main study goal is to conduct a cost identification analysis to
determine if there are healthcare cost savings for dementia patients associated with their caregivers'
participation in a successful behavioral intervention to improve their own coping and patient management. We
will also examine whether participation in the intervention results in healthcare use and cost savings for
caregivers. We propose to integrate patient and caregiver data from two previous studies of successful
behavioral interventions for dementia caregivers with Medicare and VA healthcare use and cost data. The first
study was the national randomized controlled trial Resources for Enhancing Alzheimer's Caregiver Health
(REACH II), conducted from 2000 to 2003, with 642 caregiving dyads from 5 sites. The second study was the
national clinical translation of REACH II into the Department of Veterans Affairs healthcare system, REACH
VA, with 127 dyads from 29 sites, conducted from 2007-2009. For the REACH II data, half the caregivers
received the behavioral intervention designed to assist with their own coping and the management of the
patient's dementia related behaviors; the other half received usual care. For each patient, we will examine
Medicare healthcare use (e.g., physician visits) and their associated costs for one year before the intervention,
for the time during the intervention, and for one year after the intervention. Use and costs will be compared for
patients whose caregivers received the intervention vs. those who did not and for caregivers who received the
intervention vs. those who did not. For the REACH VA study, all caregivers received the intervention. Both VA
and Medicare use and costs will be compared for the patients whose caregivers received the intervention vs. a
matched comparison group of other VA patients with dementia. For all groups, we will determine if use and
costs are different for different types of patients and caregivers (e.g., those of different races or ethnicities).
尽管对痴呆症照顾者的行为干预已被证明会减少照顾者
压力和负担,很少有人研究它们对患者或
照顾者。缺乏关于干预措施对医疗费用的影响的信息,特别是对痴呆症的影响
这很可能阻碍了成功干预措施的广泛采用。建议的研究内容包括
我们对照顾者是否有成功的行为干预的理解上存在重要的知识差距
对患者和照顾者的实际医疗成本有影响,以及这些影响是否因
护理者和患者的特征。我们的主要研究目标是进行成本识别分析,以
确定是否有与照顾者相关的痴呆症患者的医疗成本节省
参与成功的行为干预,提高自身应对能力和患者管理水平。我们
还将检查参与干预是否会导致医疗保健使用和成本节约
照顾者。我们建议整合患者和护理者的数据,这些数据来自之前两项成功的研究
使用联邦医疗保险和退伍军人管理局的医疗保健使用和费用数据对痴呆症照顾者进行行为干预。第一
这项研究是提高阿尔茨海默病照顾者健康的国家随机对照试验资源
(REACH II),从2000年到2003年进行,来自5个地点的642名照顾双胞胎。第二项研究是
REACH II全国临床翻译成退伍军人事务部医疗保健系统REACH
来自29个站点的127个二联体,从2007年到2009年进行。对于REACH II的数据,一半的照顾者
接受旨在帮助他们自己应对和管理的行为干预
患者的痴呆相关行为;另一半接受常规护理。对于每一位患者,我们都会检查
干预前一年的医疗保险保健使用(例如,医生就诊)及其相关费用,
在干预期间和干预后的一年内。将对使用情况和成本进行比较
照顾者接受干预的患者与未接受干预的患者和接受干预的照顾者
干预VS那些没有这样做的人。在REACH VA研究中,所有照顾者都接受了干预。两者均为VA
并将对接受护理人员干预的患者的医疗保险使用情况和成本进行比较
与之匹配的对照组为其他VA痴呆患者。对于所有组,我们将确定是否使用和
对于不同类型的患者和照顾者(例如,不同种族或民族的人),费用是不同的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LINDA O. NICHOLS其他文献
LINDA O. NICHOLS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LINDA O. NICHOLS', 18)}}的其他基金
Effect of Dementia Caregiver Interventions on Healthcare Cost
痴呆症护理人员干预对医疗费用的影响
- 批准号:
8743175 - 财政年份:2013
- 资助金额:
$ 21.99万 - 项目类别:
Effect of Dementia Caregiver Interventions on Healthcare Cost
痴呆症护理人员干预对医疗费用的影响
- 批准号:
8892954 - 财政年份:2013
- 资助金额:
$ 21.99万 - 项目类别:
PROVIDERS AND ALZHEIMER'S CAREGIVERS TOGETHER
医疗服务提供者和阿尔茨海默病的护理人员齐心协力
- 批准号:
6533805 - 财政年份:2000
- 资助金额:
$ 21.99万 - 项目类别:
PROVIDERS AND ALZHEIMER'S CAREGIVERS TOGETHER
医疗服务提供者和阿尔茨海默病的护理人员齐心协力
- 批准号:
6372274 - 财政年份:2000
- 资助金额:
$ 21.99万 - 项目类别:
PROVIDERS AND ALZHEIMER'S CAREGIVERS TOGETHER
医疗服务提供者和阿尔茨海默病的护理人员齐心协力
- 批准号:
6200077 - 财政年份:2000
- 资助金额:
$ 21.99万 - 项目类别:
相似海外基金
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 21.99万 - 项目类别:
Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 21.99万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 21.99万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 21.99万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 21.99万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 21.99万 - 项目类别:
EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 21.99万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 21.99万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 21.99万 - 项目类别:
Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 21.99万 - 项目类别:
Standard Grant